His main research concerns Prostate cancer, Prostate, Prostatectomy, Cancer and Cancer research. His Prostate cancer research includes themes of Tissue microarray and Pathology. The concepts of his Prostate study are interwoven with issues in Gene rearrangement and Surgical margin.
He has researched Prostatectomy in several fields, including Neurovascular bundle, Surgery, Retrospective cohort study and Urology. Thorsten Schlomm works mostly in the field of Cancer, limiting it down to topics relating to microRNA and, in certain cases, Gene silencing. The various areas that Thorsten Schlomm examines in his Cancer research study include DNA methylation, Fusion gene, Oncogene, Androgen receptor and PTEN.
His primary areas of investigation include Prostate cancer, Prostatectomy, Internal medicine, Prostate and Oncology. His Prostate cancer research is multidisciplinary, relying on both Cancer research, Tissue microarray and Pathology. His Cancer research research incorporates themes from Fusion gene, Tensin, Tumor progression and Oncogene.
His research integrates issues of Fluorescence in situ hybridization and Immunostaining in his study of Tissue microarray. His studies in Prostatectomy integrate themes in fields like Stage, Surgery, Urology, Biopsy and Cohort. His work on PCA3 and Prostate-specific antigen as part of his general Prostate study is frequently connected to Erg and TMPRSS2, thereby bridging the divide between different branches of science.
Thorsten Schlomm focuses on Prostate cancer, Cancer research, Internal medicine, Prostate and Cancer. His work carried out in the field of Prostate cancer brings together such families of science as Immunohistochemistry and Tissue microarray. His Cancer research research integrates issues from Oncogene, Downregulation and upregulation, Transcription factor, Chromatin and microRNA.
As part of one scientific family, Thorsten Schlomm deals mainly with the area of Internal medicine, narrowing it down to issues related to the Oncology, and often Cohort and DNA methylation. Thorsten Schlomm has included themes like Cancer cell, Transcriptome, Genome, Hazard ratio and PTEN in his Prostate study. Thorsten Schlomm interconnects Proportional hazards model, Surgery, Urology, Multivariate analysis and General surgery in the investigation of issues within Prostatectomy.
His primary scientific interests are in Prostate cancer, Cancer, Cancer research, Internal medicine and Oncology. Thorsten Schlomm has included themes like Prostate and Tissue microarray in his Prostate cancer study. His Prostate study combines topics in areas such as Genome, Disease and Somatic cell.
He combines subjects such as PTEN, Transcription factor, Chromatin, microRNA and Androgen receptor with his study of Cancer research. In general Internal medicine, his work in Retrospective cohort study, Case-control study and Multivariate analysis is often linked to Low volume linking many areas of study. His work deals with themes such as Urology, Systemic therapy, Bone metastasis, Proportional hazards model and Cohort, which intersect with Prostatectomy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Circulating miRNAs are correlated with tumor progression in prostate cancer.
Jan C. Brase;Marc Johannes;Thorsten Schlomm;Maria Fälth.
International Journal of Cancer (2011)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)
MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
James W F Catto;Antonio Alcaraz;Anders S. Bjartell;Ralph W deVere White.
European Urology (2011)
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
Joachim Weischenfeldt;Ronald Simon;Lars Feuerbach;Karin Schlangen.
Cancer Cell (2013)
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
Antje Krohn;Tobias Diedler;Lia Burkhardt;Pascale Sophie Mayer.
American Journal of Pathology (2012)
Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))
Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta.
EVALUATION OF PROSTATE CANCER DETECTION WITH REAL- TIME-ELASTOGRAPHY: A COMPARISON WITH STEP SECTION PATHOLOGICAL ANALYSIS AFTER RADICAL PROSTATECTOMY
G. Salomon;J. Köllermann;I. Thederan;T. Schlomm.
European Urology Supplements (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: